Please login to the form below
Top 20 pharma companies by cardiovascular sales
The ranking of the top pharmaceutical companies has been compiled from GlobalData's pharmaceutical revenue figures, which are based on sales of prescription medicines, including generics drugs. The rankings include historical data from 2011 to 2016 and forecast data for 2017 to 2023.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
-
Medical Writer
-
Salary TBC
-
Experienced Medical Writers
-
Competitive Salary and Benefits
-
Systematic Reviewer - Oxford
-
Negotiable
-
Associate Director
-
£75, 000-90, 000
- Account Executive/ Senior Account Executive
-
competitive Salary Offfered
-
Account Manager
-
Negotiable
- Manager - Immunology, Therapeutic Area Communications & Publ...
-
Competitive Salary Offered
- Business Development Director – Health Education
-
excellent commission
-
Senior Account Manager
-
Competitive Salary Offered
- Senior Account Executive with progression to Account Manager, Me...
-
Excellent package
-
Business Director
-
Competitive Salary Offered
- Principal Health Economist - North-West
-
Negotiable
-
Medical Writer
-
Bonus Scheme, PTO &Private Healthcare
-
Medical (Scientific) Director
-
£120, 000 benefits
-
Account Manager / Account Director
-
Competative
-
Account Director
-
Competitive Salary Offered
Subscribe to our email news alerts
- Is China ready for a pharmaceutical gold rush?
- We've moved!
- NICE says no to rival Alnylam and Akcea amyliodsis drugs – but deal could be done
- Dragonfly signs Celgene as partner for NK cell platform
- NICE appraisal fees to be introduced despite opposition
- AZ still sees route to approval for Imfinzi in MYSTIC trial
PMHub
Star
We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...
Latest intelligence
- Is China ready for a pharmaceutical gold rush?
- Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
- AstraZeneca’s oncology renaissance
- Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
- Navigating the antibiotic resistance crisis
- Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Quick links
Infographics
